Hiatt Robert A, Sibley Amanda, Venkatesh Brinda, Cheng Joyce, Dixit Niharika, Fox Rena, Ling Pamela, Nguyen Tung, Oh Debora, Palmer Nynikka R, Pasick Rena J, Potter Michael B, Somsouk Ma, Vargas Roberto Ariel, Vijayaraghavan Maya, Ashworth Alan
Department of Epidemiology and Biostatistics, UCSF, San Francisco, USA.
Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA.
Curr Epidemiol Rep. 2022;9(1):10-21. doi: 10.1007/s40471-021-00280-7. Epub 2022 Mar 21.
Cancer incidence and mortality are decreasing, but inequities in outcomes persist. This paper describes the San Francisco Cancer Initiative (SF CAN) as a model for the systematic application of epidemiological evidence to reduce the cancer burden and associated inequities.
SF CAN is a multi-institutional implementation of existing evidence on the prevention and early detection of five common cancers (i.e., breast, prostate, colorectal, liver, and lung/tobacco-related cancers) accounting for 50% of cancer deaths in San Francisco. Five Task Forces follow individual logic models designating inputs, outputs, and outcomes. We describe the progress made and the challenges faced by each Task Force after 5 years of activity.
SF CAN is a model for how the nation's Comprehensive Cancer Centers are ideally positioned to leverage cancer epidemiology for evidence-based initiatives that, along with genuine community engagement and multiple stakeholders, can reduce the population burden of cancer.
癌症发病率和死亡率正在下降,但结果的不平等现象依然存在。本文将旧金山癌症倡议(SF CAN)描述为一个系统性应用流行病学证据以减轻癌症负担及相关不平等现象的典范。
SF CAN是对预防和早期发现五种常见癌症(即乳腺癌、前列腺癌、结直肠癌、肝癌以及肺癌/与烟草相关的癌症)的现有证据进行的多机构实施,这五种癌症占旧金山癌症死亡人数的50%。五个特别工作组遵循各自指定投入、产出和结果的逻辑模型。我们描述了各特别工作组在开展活动5年后取得的进展和面临的挑战。
SF CAN是一个典范,展示了美国的综合癌症中心如何能够利用癌症流行病学开展基于证据的倡议,这些倡议与真正的社区参与和多个利益相关者一起,可以减轻人群的癌症负担。